Clinical Outcomes in Patients with Rheumatoid Arthritis After Switching Between Interleukin-6-Receptor Inhibitors and Janus Kinase Inhibitors: Findings from an Observational Study

INTRODUCTION: This observational study evaluated response in patients with rheumatoid arthritis (RA) who switched from an interleukin-6 receptor inhibitor (IL-6Ri) to a Janus kinase inhibitor (JAKi) and vice versa. METHODS: Adult patients with RA, who initiated IL-6Ri or JAKi (following discontinuat...

Descripción completa

Detalles Bibliográficos
Autores principales: Dua, Anisha B., Ford, Kerri, Fiore, Stefano, Pappas, Dimitrios A., Janak, Jud C., Blachley, Taylor, Roberts-Toler, Carla, Emeanuru, Kelechi, Kremer, Joel M., Kivitz, Alan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10654323/
https://www.ncbi.nlm.nih.gov/pubmed/37906399
http://dx.doi.org/10.1007/s40744-023-00609-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10654323/
https://www.ncbi.nlm.nih.gov/pubmed/37906399
http://dx.doi.org/10.1007/s40744-023-00609-2

Ejemplares similares